Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19

BACKGROUND After its introduction as standard-of-care for severe COVID-19, dexamethasone has been administered to a large number of patients globally. Detailed knowledge of its impact on the cellular and humoral immune response to SARS-CoV-2 remains scarce.METHODS We included immunocompetent individ...

Full description

Bibliographic Details
Main Authors: Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, Veronica di Cristanziano, Kirsten A. Eberhardt, Paula Stubbemann, David Hillus, Pinkus Tober-Lau, Parnika Mukherjee, Friederike Münn, Lena J. Lippert, Elisa T. Helbig, Tilman Lingscheid, Fridolin Steinbeis, Mirja Mittermaier, Martin Witzenrath, Thomas Zoller, Pa-COVID study group, Florian Klein, Leif E. Sander, Florian Kurth
Format: Article
Language:English
Published: American Society for Clinical investigation 2023-04-01
Series:JCI Insight
Subjects:
Immunology
Infectious disease
Online Access:https://doi.org/10.1172/jci.insight.166711

Internet

https://doi.org/10.1172/jci.insight.166711

Similar Items